Comparative Pharmacology
Head-to-head clinical analysis: FLUTEX versus HYTONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLUTEX versus HYTONE.
FLUTEX vs HYTONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Flutamide is a nonsteroidal antiandrogen that competitively inhibits the binding of dihydrotestosterone (DHT) to androgen receptors in target tissues, thereby blocking the androgenic effects.
Hydrocortisone (topical) binds to glucocorticoid receptors, activating anti-inflammatory proteins and inhibiting phospholipase A2, thereby reducing prostaglandin and leukotriene synthesis.
50 mg orally once daily
Topical: Apply cream or ointment to affected area 2-4 times daily. Limit treatment area to less than 50% of body surface area. Maximum duration: 2 weeks unless directed by physician.
None Documented
None Documented
Terminal elimination half-life: 24–36 hours, permitting once-daily dosing in chronic therapy
30–60 minutes (terminal elimination half-life; short duration requires frequent dosing)
Renal: ~70% (50% unchanged, 20% as metabolites); Biliary/fecal: ~30%
Renal (primarily as metabolites; ~25% as unchanged drug) and biliary/fecal
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid